受强制性开放获取政策约束的文章 - Kris Thielemans了解详情
无法在其他位置公开访问的文章：10 篇
Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma
S Wilgenhof, AMT Van Nuffel, J Corthals, C Heirman, S Tuyaerts, ...
Journal of immunotherapy 34 (5), 448-456, 2011
强制性开放获取政策： Research Foundation (Flanders)
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption
SD Allard, B De Keersmaecker, AL de Goede, EJ Verschuren, J Koetsveld, ...
Clinical immunology 142 (3), 252-268, 2012
强制性开放获取政策： Research Foundation (Flanders)
Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix)
AC Guardo, PT Joe, L Miralles, ME Bargalló, B Mothe, A Krasniqi, ...
Aids 31 (3), 321-332, 2017
强制性开放获取政策： Research Foundation (Flanders), Government of Spain
Immune checkpoint blockade combined with IL‐6 and TGF‐β inhibition improves the therapeutic outcome of m RNA‐based immunotherapy
L Bialkowski, K Van der Jeught, S Bevers, P Tjok Joe, D Renmans, ...
International journal of cancer 143 (3), 686-698, 2018
强制性开放获取政策： Research Foundation (Flanders)
In vitro generation of mature, naive antigen-specific CD8+ T cells with a single T-cell receptor by agonist selection
S Snauwaert, G Verstichel, S Bonte, G Goetgeluk, S Vanhee, ...
Leukemia 28 (4), 830-841, 2014
强制性开放获取政策： Research Foundation (Flanders), UK Medical Research Council
Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigens
AMT Van Nuffel, S Tuyaerts, D Benteyn, S Wilgenhof, J Corthals, ...
Journal of immunological methods 377 (1-2), 23-36, 2012
强制性开放获取政策： Research Foundation (Flanders)
mRNA: delivering an antitumor message?
S Van Lint, K Thielemans, K Breckpot
Immunotherapy 3 (5), 605-607, 2011
强制性开放获取政策： Research Foundation (Flanders)
HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption
AL de Goede, HWM van Deutekom, B Vrancken, M Schutten, SD Allard, ...
Aids 27 (17), 2679-2689, 2013
强制性开放获取政策： Research Foundation (Flanders)
mRNA electroporation of dendritic cells with WT1, survivin, and TriMix (a mixture of caTLR4, CD40L, and CD70)
A Coosemans, S Tuyaerts, K Morias, J Corthals, C Heirman, ...
Synthetic mRNA: production, introduction into cells, and physiological …, 2016
强制性开放获取政策： Research Foundation (Flanders)
Engineering WT1-encoding mRNA to increase translational efficiency in dendritic cells
D Benteyn, C Heirman, K Thielemans, A Bonehill
Synthetic mRNA: Production, Introduction Into Cells, and Physiological …, 2016
强制性开放获取政策： Research Foundation (Flanders)
可在其他位置公开访问的文章：77 篇
Lung-resident eosinophils represent a distinct regulatory eosinophil subset
C Mesnil, S Raulier, G Paulissen, X Xiao, MA Birrell, D Pirottin, T Janss, ...
The Journal of clinical investigation 126 (9), 3279-3295, 2016
强制性开放获取政策： National Fund for Scientific Research, Belgium, European Commission
Phase II study of autologous monocyte-derived mRNA electroporated dendritic cells (TriMixDC-MEL) plus ipilimumab in patients with pretreated advanced melanoma
S Wilgenhof, J Corthals, C Heirman, N van Baren, S Lucas, P Kvistborg, ...
Journal of Clinical Oncology 34 (12), 1330-1338, 2016
强制性开放获取政策： Research Foundation (Flanders)
Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients
A Bonehill, AMT Van Nuffel, J Corthals, S Tuyaerts, C Heirman, ...
Clinical Cancer Research 15 (10), 3366-3375, 2009
强制性开放获取政策： Research Foundation (Flanders)
Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy
S Van Lint, C Goyvaerts, S Maenhout, L Goethals, A Disy, D Benteyn, ...
Cancer research 72 (7), 1661-1671, 2012
强制性开放获取政策： US National Institutes of Health, Research Foundation (Flanders)
A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
S Wilgenhof, AMT Van Nuffel, D Benteyn, J Corthals, C Aerts, C Heirman, ...
Annals of Oncology 24 (10), 2686-2693, 2013
强制性开放获取政策： Research Foundation (Flanders)
Current approaches in dendritic cell generation and future implications for cancer immunotherapy
S Tuyaerts, JL Aerts, J Corthals, B Neyns, C Heirman, K Breckpot, ...
Cancer Immunology, Immunotherapy 56, 1513-1537, 2007
强制性开放获取政策： Research Foundation (Flanders)
Immunomodulation of the tumor microenvironment: turn foe into friend
H Locy, S De Mey, W De Mey, M De Ridder, K Thielemans, SK Maenhout
Frontiers in immunology 9, 2909, 2018
强制性开放获取政策： Research Foundation (Flanders)
Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA
A Bonehill, S Tuyaerts, AMT Van Nuffel, C Heirman, TJ Bos, K Fostier, ...
Molecular Therapy 16 (6), 1170-1180, 2008
强制性开放获取政策： Research Foundation (Flanders)
mRNA-based dendritic cell vaccines
D Benteyn, C Heirman, A Bonehill, K Thielemans, K Breckpot
Expert review of vaccines 14 (2), 161-176, 2015
强制性开放获取政策： Research Foundation (Flanders)
The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy
H Dewitte, S Van Lint, C Heirman, K Thielemans, SC De Smedt, ...
Journal of Controlled Release 194, 28-36, 2014
强制性开放获取政策： Research Foundation (Flanders)
出版信息和资助信息由计算机程序自动确定